Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by 501Y.v2 (lineage B.1.351) in the Eastern Cape, South Africa

Oluwakemi Laguda Akingba, Kaitlin Sprong, Diana Ruth Hardie
doi: https://doi.org/10.1101/2021.02.03.21251057

Article Information

doi 
https://doi.org/10.1101/2021.02.03.21251057
History 
  • February 5, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Oluwakemi Laguda Akingbaa,b,*,
  2. Kaitlin Spronga,b,* and
  3. Diana Ruth Hardiea,c,*
  1. aNational Health Laboratory Service, South Africa
  2. bDepartment of Laboratory Medicine and Pathology, Faculty of Health Sciences, Walter Sisulu University, Mthatha, South Africa
  3. cDivision of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa
  1. ↵*Corresponding author: Diana Hardie, C18 Laboratory, Groote Schuur Hospital, Anzio Rd Observatory, 7925, Cape Town, South Africa, E mail: diana.hardie{at}uct.ac.za, Oluwakemi Laguda Akingba, e mail: Oluwakemi.LA{at}nhls.ac.za, Kaitlin Sprong, e mail: Kaitlin.sprong{at}nhls.ac.za
Back to top
Posted February 05, 2021.
Download PDF
Data/Code
Email
Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by 501Y.v2 (lineage B.1.351) in the Eastern Cape, South Africa
Oluwakemi Laguda Akingba, Kaitlin Sprong, Diana Ruth Hardie
medRxiv 2021.02.03.21251057; doi: https://doi.org/10.1101/2021.02.03.21251057
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area